Institutional Ownership Aquestive Therapeutics, Inc. (AQST)
This table provides information about the institutional ownership of Aquestive Therapeutics, Inc. (AQST). We have compiled data on the 126 institutions that hold shares in the stock, with a total of 47.6 Million shares, which have been reported (via 13F filing form) to have a value of $180 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
298,016
shares
|
$1.13 Million
0.0% of portfolio
|
Q1 2025
Added 294.72%
|
|
Financial Engines Advisors L.L.C.
Santa Clara, CA |
Aug 13, 2025 Q2 2025 |
272,686
shares
|
$1.03 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
245,299
shares
|
$927,230
0.0% of portfolio
|
Q2 2025
Added 19.34%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
244,396
shares
|
$923,816
0.0% of portfolio
|
Q2 2025
Added 15.99%
|
|
Latash Investments, LLC
Anchorage, AK |
Aug 13, 2025 Q2 2025 |
243,134
shares
|
$919,046
0.62% of portfolio
|
Q2 2021
New holding
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
239,914
shares
|
$906,874
0.0% of portfolio
|
Q2 2025
Reduced 35.52%
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 13, 2025 Q2 2025 |
237,904
shares
|
$899,277
0.0% of portfolio
|
Q2 2025
Added 501.06%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
236,473
shares
|
$893,867
0.0% of portfolio
|
Q3 2024
Reduced 69.88%
|
|
Cahill Wealth Management, LLC
Portage, MI |
May 12, 2025 Q1 2025 |
218,381
shares
|
$825,480
0.32% of portfolio
|
Q1 2025
Added 52.66%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
201,417
shares
|
$761,356
0.0% of portfolio
|
Q2 2025
Reduced 14.82%
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
186,692
shares
|
$705,695
0.04% of portfolio
|
Q2 2025
New holding
|
|
Diametric Capital, LP
Boston, MA |
Aug 13, 2025 Q2 2025 |
165,373
shares
|
$625,109
0.37% of portfolio
|
Q2 2025
New holding
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Aug 13, 2025 Q2 2025 |
163,453
shares
|
$617,852
0.0% of portfolio
|
Q2 2025
Reduced 7.26%
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
153,828
shares
|
$581,469
0.0% of portfolio
|
Q2 2025
Added 85.43%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
152,156
shares
|
$575,149
0.0% of portfolio
|
Q2 2025
Reduced 66.89%
|
|
Entry Point Capital, LLC
New York, NY |
Aug 11, 2025 Q2 2025 |
149,156
shares
|
$563,809
0.26% of portfolio
|
Q2 2025
Reduced 22.62%
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Aug 14, 2025 Q2 2025 |
142,000
shares
|
$536,760
0.14% of portfolio
|
Q1 2025
Added 11.81%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
140,872
shares
|
$532,496
0.0% of portfolio
|
Q2 2025
Added 34.98%
|
|
Russell Investments Group, Ltd.
|
Aug 13, 2025 Q2 2025 |
127,704
shares
|
$482,721
0.0% of portfolio
|
Q2 2025
Added 1.76%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
117,700
shares
|
$444,906
0.01% of portfolio
|
Q2 2025
Reduced 29.82%
|
|
Chartwell Investment Partners, LLC
|
Nov 04, 2024 Q3 2024 |
107,550
shares
|
$406,539
0.02% of portfolio
|
Q3 2024
New holding
|
|
Wells Fargo & Company
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
103,431
shares
|
$390,969
0.0% of portfolio
|
Q2 2025
Added 86.52%
|
|
High Tower Advisors, LLC
Chicago, IL |
Aug 11, 2025 Q2 2025 |
99,613
shares
|
$376,537
0.0% of portfolio
|
Q2 2025
Reduced 8.33%
|
|
Creative Planning
Overland Park, KS |
Aug 08, 2025 Q2 2025 |
98,751
shares
|
$373,278
0.0% of portfolio
|
Q2 2025
Added 15.34%
|
|
Alliancebernstein L.P.
New York, NY |
Aug 14, 2025 Q2 2025 |
88,090
shares
|
$332,980
0.0% of portfolio
|
Q2 2025
Added 113.34%
|